The role of antiplatelet therapy in aneurysm coiling

Rudy J. Rahme, Samer G. Zammar, Tarek Y El Ahmadieh, Najib E El Tecle, Sameer A. Ansari, Bernard Bendok

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Neurointerventional surgery offers the potential to deliver remarkable intravascular therapies for various neurovascular diseases and stroke. This approach, however, carries a risk of complications that need to be kept to a minimum. Thromboembolism is one of the most consequential complications of neurointerventional surgery in the treatment of intracranial aneurysms. Both antiplatelet and anticoagulant therapies have shown to reduce the risk of thromboembolism in this setting. In this paper, we review the role of antiplatelet therapy in the endovascular management of intracranial aneurysms. For unruptured aneurysms, the use of antiplatelet agents to pre-medicate patients before and during the procedure appears safe and effective in reducing the thrombotic risk. Abciximab has not been extensively studied, but seems to be safe as a salvage maneuver in the case of thrombus formation even in ruptured aneurysms (when the dome is relatively secure) with low rates of intraprocedure and procedure hemorrhagic complications. Further innovation and research are needed to further reduce thromboembolic risks of aneurysm coiling.

Original languageEnglish (US)
Pages (from-to)383-388
Number of pages6
JournalNeurological Research
Volume36
Issue number4
DOIs
StatePublished - 2014
Externally publishedYes

Fingerprint

Aneurysm
Thromboembolism
Intracranial Aneurysm
Ruptured Aneurysm
Platelet Aggregation Inhibitors
Therapeutics
Anticoagulants
Thrombosis
Stroke
Research

Keywords

  • Abciximab
  • Aneurysm
  • Antiplatelet therapy
  • Aspirin
  • Clopidogrel
  • Coiling
  • Complication
  • Thromboembolism

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology
  • Medicine(all)

Cite this

Rahme, R. J., Zammar, S. G., Ahmadieh, T. Y. E., Tecle, N. E. E., Ansari, S. A., & Bendok, B. (2014). The role of antiplatelet therapy in aneurysm coiling. Neurological Research, 36(4), 383-388. https://doi.org/10.1179/1743132814Y.0000000317

The role of antiplatelet therapy in aneurysm coiling. / Rahme, Rudy J.; Zammar, Samer G.; Ahmadieh, Tarek Y El; Tecle, Najib E El; Ansari, Sameer A.; Bendok, Bernard.

In: Neurological Research, Vol. 36, No. 4, 2014, p. 383-388.

Research output: Contribution to journalArticle

Rahme, RJ, Zammar, SG, Ahmadieh, TYE, Tecle, NEE, Ansari, SA & Bendok, B 2014, 'The role of antiplatelet therapy in aneurysm coiling', Neurological Research, vol. 36, no. 4, pp. 383-388. https://doi.org/10.1179/1743132814Y.0000000317
Rahme, Rudy J. ; Zammar, Samer G. ; Ahmadieh, Tarek Y El ; Tecle, Najib E El ; Ansari, Sameer A. ; Bendok, Bernard. / The role of antiplatelet therapy in aneurysm coiling. In: Neurological Research. 2014 ; Vol. 36, No. 4. pp. 383-388.
@article{c0a0683a80534ea282fd61e99dd4d5d0,
title = "The role of antiplatelet therapy in aneurysm coiling",
abstract = "Neurointerventional surgery offers the potential to deliver remarkable intravascular therapies for various neurovascular diseases and stroke. This approach, however, carries a risk of complications that need to be kept to a minimum. Thromboembolism is one of the most consequential complications of neurointerventional surgery in the treatment of intracranial aneurysms. Both antiplatelet and anticoagulant therapies have shown to reduce the risk of thromboembolism in this setting. In this paper, we review the role of antiplatelet therapy in the endovascular management of intracranial aneurysms. For unruptured aneurysms, the use of antiplatelet agents to pre-medicate patients before and during the procedure appears safe and effective in reducing the thrombotic risk. Abciximab has not been extensively studied, but seems to be safe as a salvage maneuver in the case of thrombus formation even in ruptured aneurysms (when the dome is relatively secure) with low rates of intraprocedure and procedure hemorrhagic complications. Further innovation and research are needed to further reduce thromboembolic risks of aneurysm coiling.",
keywords = "Abciximab, Aneurysm, Antiplatelet therapy, Aspirin, Clopidogrel, Coiling, Complication, Thromboembolism",
author = "Rahme, {Rudy J.} and Zammar, {Samer G.} and Ahmadieh, {Tarek Y El} and Tecle, {Najib E El} and Ansari, {Sameer A.} and Bernard Bendok",
year = "2014",
doi = "10.1179/1743132814Y.0000000317",
language = "English (US)",
volume = "36",
pages = "383--388",
journal = "Neurological Research",
issn = "0161-6412",
publisher = "Maney Publishing",
number = "4",

}

TY - JOUR

T1 - The role of antiplatelet therapy in aneurysm coiling

AU - Rahme, Rudy J.

AU - Zammar, Samer G.

AU - Ahmadieh, Tarek Y El

AU - Tecle, Najib E El

AU - Ansari, Sameer A.

AU - Bendok, Bernard

PY - 2014

Y1 - 2014

N2 - Neurointerventional surgery offers the potential to deliver remarkable intravascular therapies for various neurovascular diseases and stroke. This approach, however, carries a risk of complications that need to be kept to a minimum. Thromboembolism is one of the most consequential complications of neurointerventional surgery in the treatment of intracranial aneurysms. Both antiplatelet and anticoagulant therapies have shown to reduce the risk of thromboembolism in this setting. In this paper, we review the role of antiplatelet therapy in the endovascular management of intracranial aneurysms. For unruptured aneurysms, the use of antiplatelet agents to pre-medicate patients before and during the procedure appears safe and effective in reducing the thrombotic risk. Abciximab has not been extensively studied, but seems to be safe as a salvage maneuver in the case of thrombus formation even in ruptured aneurysms (when the dome is relatively secure) with low rates of intraprocedure and procedure hemorrhagic complications. Further innovation and research are needed to further reduce thromboembolic risks of aneurysm coiling.

AB - Neurointerventional surgery offers the potential to deliver remarkable intravascular therapies for various neurovascular diseases and stroke. This approach, however, carries a risk of complications that need to be kept to a minimum. Thromboembolism is one of the most consequential complications of neurointerventional surgery in the treatment of intracranial aneurysms. Both antiplatelet and anticoagulant therapies have shown to reduce the risk of thromboembolism in this setting. In this paper, we review the role of antiplatelet therapy in the endovascular management of intracranial aneurysms. For unruptured aneurysms, the use of antiplatelet agents to pre-medicate patients before and during the procedure appears safe and effective in reducing the thrombotic risk. Abciximab has not been extensively studied, but seems to be safe as a salvage maneuver in the case of thrombus formation even in ruptured aneurysms (when the dome is relatively secure) with low rates of intraprocedure and procedure hemorrhagic complications. Further innovation and research are needed to further reduce thromboembolic risks of aneurysm coiling.

KW - Abciximab

KW - Aneurysm

KW - Antiplatelet therapy

KW - Aspirin

KW - Clopidogrel

KW - Coiling

KW - Complication

KW - Thromboembolism

UR - http://www.scopus.com/inward/record.url?scp=84896279044&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84896279044&partnerID=8YFLogxK

U2 - 10.1179/1743132814Y.0000000317

DO - 10.1179/1743132814Y.0000000317

M3 - Article

C2 - 24617939

AN - SCOPUS:84896279044

VL - 36

SP - 383

EP - 388

JO - Neurological Research

JF - Neurological Research

SN - 0161-6412

IS - 4

ER -